Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.74 |
| ▸ | ACHE | P22303 | 9/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | SNCA | P37840 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | FDPS | P14324 | 3/20 | 0.64 |
| ▸ | APP | P05067 | 2/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7552212 | 1.00 | KDM4E (0.74) | KDM4EACHEALDH1A1HPGDALOX15 | |
| SCHEMBL6879248 | 0.99 | KDM4E (0.76) | KDM4EACHEALDH1A1HPGDALOX15 | |
| SCHEMBL13168869 | 0.95 | KDM4E (0.82) | KDM4EACHEALDH1A1HPGDALOX15 | |
| SCHEMBL13168868 | 0.95 | KDM4E (0.82) | KDM4EACHEALDH1A1HPGDALOX15 | |
| Cinametic Acid SCHEMBL29926813 | 0.91 | KDM4E (0.80) | KDM4EACHEALDH1A1HPGDALOX15 | |
| Cinametic Acid SCHEMBL11681943 | 0.91 | KDM4E (0.80) | KDM4EACHEALDH1A1HPGDALOX15 | |
| Cinametic Acid SCHEMBL555131 | 0.91 | KDM4E (0.80) | KDM4EACHEALDH1A1HPGDALOX15 | |
| SCHEMBL13168863 | 0.91 | KDM4E (0.84) | KDM4EACHEALDH1A1HPGDALOX15 | |
| SCHEMBL6026520 | 0.90 | KDM4E (0.74) | KDM4EACHEALDH1A1HPGDALOX15 | |
| SCHEMBL7966392 | 0.90 | KDM4E (0.83) | KDM4EACHEALDH1A1HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9493394-B2 | Photoaligning materials | ROLIC AG (CH) | 2016-11-15 | — | — | US | disclosed |
| US-9334366-B2 | Photoaligning materials | ROLIC AG (CH) | 2016-05-10 | — | — | US | disclosed |
| US-20140342086-A1 | PHOTOALIGNING MATERIALS | ROLIC AG (CH) | 2014-11-20 | — | — | US | disclosed |
| US-20140249244-A1 | PHOTOALIGNING MATERIALS | ROLIC AG (CH) | 2014-09-04 | — | — | US | disclosed |
| EP-2763957-A1 | PHOTOALIGNING MATERIALS | Rolic AG (CH) | 2014-08-13 | — | — | EP | disclosed |
| WO-2013050121-A1 | PHOTOALIGNING MATERIALS | ROLIC AG (CH) | 2013-04-11 | — | — | WO | disclosed |
| US-5965761-A | CROSSLINKABLE SILANE DERIVAATIVES HAVING A 3-ARYLACRYLIC ACID OR-ACRYLAMIDE GROUP FOR ORIENTING LAYER AND FOR NONSTRUCTURED AND STRUCTURED OPTICAL ELEMENTS AND MULTILAYER SYSTEMS; PHOTOSTABILITY; CONTRAST; RESOLUTION | ROLIC AG (CH) | 1999-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249244-A1 | PHOTOALIGNING MATERIALS | LCP1, PIN1, MAP1LC3C | KDM4E 4712/4885ACHE 4136/4885ALDH1A1 4459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.